Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
This study has been completed.
Herbert Irving Comprehensive Cancer Center
Information provided by:
National Cancer Institute (NCI)
First received: January 6, 2001
Last updated: February 1, 2013
Last verified: May 2003
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2008|
|Primary Completion Date:||December 2005 (Final data collection date for primary outcome measure)|
Cohen DJ, Vahdat LT, Zipin D, et al.: Randomized trial of low-dose interleukin-2 vs. cyclosporine A and interferon- after high dose chemotherapy with peripheral blood progenitor support in women with high risk primary breast cancer (HRPBC). [Abstract] Breast Cancer Res Treat 88 (1): A-2079, 2004.